Autologous osteoperiosteal transplantation is effective in the treatment of single cystic osteochondral lesions of the talus and the prognostic impact of age should be emphasized

ShiHang Cao,Nan Ding,Qiang Zan,Jun Lu,Yi Li,Feng Tian,JunKui Xu
DOI: https://doi.org/10.1002/ksa.12301
2024-06-02
Knee Surgery Sports Traumatology Arthroscopy
Abstract:Purpose To investigate the clinical efficacy and prognostic factors associated with autologous osteoperiosteal transplantation for the treatment of single cystic osteochondral lesions of the talus (OLT). Methods The clinical data of patients with single cystic OLT undergoing autologous osteoperiosteal transplantation at the Department of Foot and Ankle Surgery of our hospital between 2018 and 2022, including complete follow‐up, were retrospectively analyzed. Imaging data from each patient were imported into Mimics software to measure the surface area, volume and depth of the lesions. Then, the talus nine‐compartment partitioning method was used to partition the injury site. Preoperative and final follow‐up assessments were performed using the American Orthopaedic Foot and Ankle Society (AOFAS) score, visual analogue scale (VAS) for pain and 36‐item Short‐Form Health Survey (SF‐36) to evaluate treatment efficacy and analyze prognostic factors. Results Of the 31 patients with single cystic OLT with a complete set of follow‐up data, there were 17 males and 14 females, with a mean age of 43.3 ± 13.6 years, a mean follow‐up time of 30.1 ± 14.0 months and a mean illness duration of 30.4 ± 20.0 months. The postoperative final follow‐up AOFAS score was 90.7 ± 5.5; this represented significant improvement when compared to the preoperative score of 57.0 ± 8.5 (P
surgery,orthopedics,sport sciences
What problem does this paper attempt to address?